Bandar Alqarni/X
Sep 29, 2025, 11:36
Bandar Alqarni: Smoflipid 20% Use in IVF Protocols
Bandar Alqarni, Pharmacist in Riyadh, shared a post on X:
“Smoflipid 20% is gaining attention for its off-label use in IVF protocols, especially in cases of Recurrent Implantation Failure (RIF) or Recurrent Pregnancy Loss (RPL).
It may help by:
- Reducing NK cell activity
- Enhancing immune tolerance
- Supporting embryo implantation
While not considered a formal treatment, it is an option in select cases after ruling out organic and chromosomal causes. Its use is under strict medical supervision, often as part of an integrated immunotherapy plan.
Always consult your fertility specialist.”
-
Sep 18, 2026, 20:27Hrishikesh Pai: Rethinking Male Infertility
-
Sep 18, 2026, 20:25Eric Verdin: Wrapping Up the Reproductive Aging Summit at the Center for Healthy Aging in Women
-
Sep 18, 2026, 20:21Investigating Pregnancy Outcomes in Women with Idiopathic POI – RBMO
-
Sep 18, 2026, 20:18Sue Ritchie: Why Aren’t We Talking About Male Fertility More?
-
Sep 18, 2026, 20:13Salma Yasin: Every Day of BFS Study Week 2026 Has Been an Exceptional Learning Experience
-
Sep 18, 2026, 20:01Qingcai Wang: Over 35 and Torn Between Trying Longer and Starting IVF?
-
Sep 18, 2026, 19:58Bhumika: Can a Woman Become Pregnant Again While Already Pregnant?
-
Sep 18, 2026, 19:5215 More Experts Join the International Fertility Forum Mumbai 2026
-
Sep 18, 2026, 19:50Curious About What Happens Behind the Scenes in the Labs? – Sims IVF